[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Immune Checkpoint Inhibitor Sales Market Report 2016

November 2016 | 108 pages | ID: GFDE39EE46AEN
QYResearch

US$ 4,000.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Notes:

Sales, means the sales volume of Immune Checkpoint Inhibitor

Revenue, means the sales value of Immune Checkpoint Inhibitor

This report studies sales (consumption) of Immune Checkpoint Inhibitor in Global market, especially in United States, China, Europe, Japan, focuses on top players in these regions/countries, with sales, price, revenue and market share for each player in these regions, covering
  • Bristol-Myers Squibb
  • Eli Lilly and Company
  • Merck & Co.
  • Roche
  • Taiho Pharmaceutical
  • Sumitomo Dainippon Pharma
Market Segment by Regions, this report splits Global into several key Regions, with sales (consumption), revenue, market share and growth rate of Immune Checkpoint Inhibitor in these regions, from 2011 to 2021 (forecast), like
  • United States
  • China
  • Europe
  • Japan
Split by product Types, with sales, revenue, price and gross margin, market share and growth rate of each type, can be divided into
  • Type I
  • Type II
  • Type III
Split by applications, this report focuses on sales, market share and growth rate of Immune Checkpoint Inhibitor in each application, can be divided into
  • Application 1
  • Application 2
  • Application 3
Global Immune Checkpoint Inhibitor Sales Market Report 2016

1 IMMUNE CHECKPOINT INHIBITOR OVERVIEW

1.1 Product Overview and Scope of Immune Checkpoint Inhibitor
1.2 Classification of Immune Checkpoint Inhibitor
  1.2.1 Type I
  1.2.2 Type II
  1.2.3 Type III
1.3 Application of Immune Checkpoint Inhibitor
  1.3.1 Application
  1.3.2 Application
  1.3.3 Application
1.4 Immune Checkpoint Inhibitor Market by Regions
  1.4.1 United States Status and Prospect (2011-2021)
  1.4.2 China Status and Prospect (2011-2021)
  1.4.3 Europe Status and Prospect (2011-2021)
  1.4.4 Japan Status and Prospect (2011-2021)
1.5 Global Market Size (Value and Volume) of Immune Checkpoint Inhibitor (2011-2021)
  1.5.1 Global Immune Checkpoint Inhibitor Sales and Growth Rate (2011-2021)
  1.5.2 Global Immune Checkpoint Inhibitor Revenue and Growth Rate (2011-2021)

2 GLOBAL IMMUNE CHECKPOINT INHIBITOR COMPETITION BY MANUFACTURERS, TYPE AND APPLICATION

2.1 Global Immune Checkpoint Inhibitor Market Competition by Manufacturers
  2.1.1 Global Immune Checkpoint Inhibitor Sales and Market Share of Key Manufacturers (2011-2016)
  2.1.2 Global Immune Checkpoint Inhibitor Revenue and Share by Manufacturers (2011-2016)
2.2 Global Immune Checkpoint Inhibitor (Volume and Value) by Type
  2.2.1 Global Immune Checkpoint Inhibitor Sales and Market Share by Type (2011-2016)
  2.2.2 Global Immune Checkpoint Inhibitor Revenue and Market Share by Type (2011-2016)
2.3 Global Immune Checkpoint Inhibitor (Volume and Value) by Regions
  2.3.1 Global Immune Checkpoint Inhibitor Sales and Market Share by Regions (2011-2016)
  2.3.2 Global Immune Checkpoint Inhibitor Revenue and Market Share by Regions (2011-2016)
2.4 Global Immune Checkpoint Inhibitor (Volume) by Application

3 UNITED STATES IMMUNE CHECKPOINT INHIBITOR (VOLUME, VALUE AND SALES PRICE)

3.1 United States Immune Checkpoint Inhibitor Sales and Value (2011-2016)
  3.1.1 United States Immune Checkpoint Inhibitor Sales and Growth Rate (2011-2016)
  3.1.2 United States Immune Checkpoint Inhibitor Revenue and Growth Rate (2011-2016)
  3.1.3 United States Immune Checkpoint Inhibitor Sales Price Trend (2011-2016)
3.2 United States Immune Checkpoint Inhibitor Sales and Market Share by Manufacturers
3.3 United States Immune Checkpoint Inhibitor Sales and Market Share by Type
3.4 United States Immune Checkpoint Inhibitor Sales and Market Share by Application

4 CHINA IMMUNE CHECKPOINT INHIBITOR (VOLUME, VALUE AND SALES PRICE)

4.1 China Immune Checkpoint Inhibitor Sales and Value (2011-2016)
  4.1.1 China Immune Checkpoint Inhibitor Sales and Growth Rate (2011-2016)
  4.1.2 China Immune Checkpoint Inhibitor Revenue and Growth Rate (2011-2016)
  4.1.3 China Immune Checkpoint Inhibitor Sales Price Trend (2011-2016)
4.2 China Immune Checkpoint Inhibitor Sales and Market Share by Manufacturers
4.3 China Immune Checkpoint Inhibitor Sales and Market Share by Type
4.4 China Immune Checkpoint Inhibitor Sales and Market Share by Application

5 EUROPE IMMUNE CHECKPOINT INHIBITOR (VOLUME, VALUE AND SALES PRICE)

5.1 Europe Immune Checkpoint Inhibitor Sales and Value (2011-2016)
  5.1.1 Europe Immune Checkpoint Inhibitor Sales and Growth Rate (2011-2016)
  5.1.2 Europe Immune Checkpoint Inhibitor Revenue and Growth Rate (2011-2016)
  5.1.3 Europe Immune Checkpoint Inhibitor Sales Price Trend (2011-2016)
5.2 Europe Immune Checkpoint Inhibitor Sales and Market Share by Manufacturers
5.3 Europe Immune Checkpoint Inhibitor Sales and Market Share by Type
5.4 Europe Immune Checkpoint Inhibitor Sales and Market Share by Application

6 JAPAN IMMUNE CHECKPOINT INHIBITOR (VOLUME, VALUE AND SALES PRICE)

6.1 Japan Immune Checkpoint Inhibitor Sales and Value (2011-2016)
  6.1.1 Japan Immune Checkpoint Inhibitor Sales and Growth Rate (2011-2016)
  6.1.2 Japan Immune Checkpoint Inhibitor Revenue and Growth Rate (2011-2016)
  6.1.3 Japan Immune Checkpoint Inhibitor Sales Price Trend (2011-2016)
6.2 Japan Immune Checkpoint Inhibitor Sales and Market Share by Manufacturers
6.3 Japan Immune Checkpoint Inhibitor Sales and Market Share by Type
6.4 Japan Immune Checkpoint Inhibitor Sales and Market Share by Application

7 GLOBAL IMMUNE CHECKPOINT INHIBITOR MANUFACTURERS ANALYSIS

7.1 Bristol-Myers Squibb
  7.1.1 Company Basic Information, Manufacturing Base and Competitors
  7.1.2 Immune Checkpoint Inhibitor Product Type, Application and Specification
    7.1.2.1 Type I
    7.1.2.2 Type II
  7.1.3 Bristol-Myers Squibb Immune Checkpoint Inhibitor Sales, Revenue, Price and Gross Margin (2011-2016)
  7.1.4 Main Business/Business Overview
7.2 Eli Lilly and Company
  7.2.1 Company Basic Information, Manufacturing Base and Competitors
  7.2.2 108 Product Type, Application and Specification
    7.2.2.1 Type I
    7.2.2.2 Type II
  7.2.3 Eli Lilly and Company Immune Checkpoint Inhibitor Sales, Revenue, Price and Gross Margin (2011-2016)
  7.2.4 Main Business/Business Overview
7.3 Merck & Co.
  7.3.1 Company Basic Information, Manufacturing Base and Competitors
  7.3.2 124 Product Type, Application and Specification
    7.3.2.1 Type I
    7.3.2.2 Type II
  7.3.3 Merck & Co. Immune Checkpoint Inhibitor Sales, Revenue, Price and Gross Margin (2011-2016)
  7.3.4 Main Business/Business Overview
7.4 Roche
  7.4.1 Company Basic Information, Manufacturing Base and Competitors
  7.4.2 Nov Product Type, Application and Specification
    7.4.2.1 Type I
    7.4.2.2 Type II
  7.4.3 Roche Immune Checkpoint Inhibitor Sales, Revenue, Price and Gross Margin (2011-2016)
  7.4.4 Main Business/Business Overview
7.5 Taiho Pharmaceutical
  7.5.1 Company Basic Information, Manufacturing Base and Competitors
  7.5.2 Product Type, Application and Specification
    7.5.2.1 Type I
    7.5.2.2 Type II
  7.5.3 Taiho Pharmaceutical Immune Checkpoint Inhibitor Sales, Revenue, Price and Gross Margin (2011-2016)
  7.5.4 Main Business/Business Overview
7.6 Sumitomo Dainippon Pharma
  7.6.1 Company Basic Information, Manufacturing Base and Competitors
  7.6.2 Million USD Product Type, Application and Specification
    7.6.2.1 Type I
    7.6.2.2 Type II
  7.6.3 Sumitomo Dainippon Pharma Immune Checkpoint Inhibitor Sales, Revenue, Price and Gross Margin (2011-2016)
  7.6.4 Main Business/Business Overview

8 IMMUNE CHECKPOINT INHIBITOR MAUFACTURING COST ANALYSIS

8.1 Immune Checkpoint Inhibitor Key Raw Materials Analysis
  8.1.1 Key Raw Materials
  8.1.2 Price Trend of Key Raw Materials
  8.1.3 Key Suppliers of Raw Materials
  8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
  8.2.1 Raw Materials
  8.2.2 Labor Cost
  8.2.3 Manufacturing Process Analysis of Immune Checkpoint Inhibitor

9 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

9.1 Immune Checkpoint Inhibitor Industrial Chain Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Raw Materials Sources of Immune Checkpoint Inhibitor Major Manufacturers in 2015
9.4 Downstream Buyers

10 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

10.1 Marketing Channel
  10.1.1 Direct Marketing
  10.1.2 Indirect Marketing
  10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
  10.2.1 Pricing Strategy
  10.2.2 Brand Strategy
  10.2.3 Target Client
10.3 Distributors/Traders List

11 MARKET EFFECT FACTORS ANALYSIS

11.1 Technology Progress/Risk
  11.1.1 Substitutes Threat
  11.1.2 Technology Progress in Related Industry
11.2 Consumer Needs/Customer Preference Change
11.3 Economic/Political Environmental Change

12 GLOBAL IMMUNE CHECKPOINT INHIBITOR MARKET FORECAST (2016-2021)

12.1 Global Immune Checkpoint Inhibitor Sales, Revenue Forecast (2016-2021)
12.2 Global Immune Checkpoint Inhibitor Sales Forecast by Regions (2016-2021)
12.3 Global Immune Checkpoint Inhibitor Sales Forecast by Type (2016-2021)
12.4 Global Immune Checkpoint Inhibitor Sales Forecast by Application (2016-2021)

13 APPENDIX

Disclosure Section
Research Methodology
Data Source
China Disclaimer

The report requires updating with new data and is sent in 2-3 business days after order is placed.
LIST OF TABLES AND FIGURES

Figure Picture of Immune Checkpoint Inhibitor
Table Classification of Immune Checkpoint Inhibitor
Figure Global Sales Market Share of Immune Checkpoint Inhibitor by Type in 2015
Figure Type I Picture
Figure Type II Picture
Table Applications of Immune Checkpoint Inhibitor
Figure Global Sales Market Share of Immune Checkpoint Inhibitor by Application in 2015
Figure Application 1 Examples
Figure Application 2 Examples
Figure United States Immune Checkpoint Inhibitor Revenue and Growth Rate (2011-2021)
Figure China Immune Checkpoint Inhibitor Revenue and Growth Rate (2011-2021)
Figure Europe Immune Checkpoint Inhibitor Revenue and Growth Rate (2011-2021)
Figure Japan Immune Checkpoint Inhibitor Revenue and Growth Rate (2011-2021)
Figure Global Immune Checkpoint Inhibitor Sales and Growth Rate (2011-2021)
Figure Global Immune Checkpoint Inhibitor Revenue and Growth Rate (2011-2021)
Table Global Immune Checkpoint Inhibitor Sales of Key Manufacturers (2011-2016)
Table Global Immune Checkpoint Inhibitor Sales Share by Manufacturers (2011-2016)
Figure 2015 Immune Checkpoint Inhibitor Sales Share by Manufacturers
Figure 2016 Immune Checkpoint Inhibitor Sales Share by Manufacturers
Table Global Immune Checkpoint Inhibitor Revenue by Manufacturers (2011-2016)
Table Global Immune Checkpoint Inhibitor Revenue Share by Manufacturers (2011-2016)
Table 2015 Global Immune Checkpoint Inhibitor Revenue Share by Manufacturers
Table 2016 Global Immune Checkpoint Inhibitor Revenue Share by Manufacturers
Table Global Immune Checkpoint Inhibitor Sales and Market Share by Type (2011-2016)
Table Global Immune Checkpoint Inhibitor Sales Share by Type (2011-2016)
Figure Sales Market Share of Immune Checkpoint Inhibitor by Type (2011-2016)
Figure Global Immune Checkpoint Inhibitor Sales Growth Rate by Type (2011-2016)
Table Global Immune Checkpoint Inhibitor Revenue and Market Share by Type (2011-2016)
Table Global Immune Checkpoint Inhibitor Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Immune Checkpoint Inhibitor by Type (2011-2016)
Figure Global Immune Checkpoint Inhibitor Revenue Growth Rate by Type (2011-2016)
Table Global Immune Checkpoint Inhibitor Sales and Market Share by Regions (2011-2016)
Table Global Immune Checkpoint Inhibitor Sales Share by Regions (2011-2016)
Figure Sales Market Share of Immune Checkpoint Inhibitor by Regions (2011-2016)
Figure Global Immune Checkpoint Inhibitor Sales Growth Rate by Regions (2011-2016)
Table Global Immune Checkpoint Inhibitor Revenue and Market Share by Regions (2011-2016)
Table Global Immune Checkpoint Inhibitor Revenue Share by Regions (2011-2016)
Figure Revenue Market Share of Immune Checkpoint Inhibitor by Regions (2011-2016)
Figure Global Immune Checkpoint Inhibitor Revenue Growth Rate by Regions (2011-2016)
Table Global Immune Checkpoint Inhibitor Sales and Market Share by Application (2011-2016)
Table Global Immune Checkpoint Inhibitor Sales Share by Application (2011-2016)
Figure Sales Market Share of Immune Checkpoint Inhibitor by Application (2011-2016)
Figure Global Immune Checkpoint Inhibitor Sales Growth Rate by Application (2011-2016)
Figure United States Immune Checkpoint Inhibitor Sales and Growth Rate (2011-2016)
Figure United States Immune Checkpoint Inhibitor Revenue and Growth Rate (2011-2016)
Figure United States Immune Checkpoint Inhibitor Sales Price Trend (2011-2016)
Table United States Immune Checkpoint Inhibitor Sales by Manufacturers (2011-2016)
Table United States Immune Checkpoint Inhibitor Market Share by Manufacturers (2011-2016)
Table United States Immune Checkpoint Inhibitor Sales by Type (2011-2016)
Table United States Immune Checkpoint Inhibitor Market Share by Type (2011-2016)
Table United States Immune Checkpoint Inhibitor Sales by Application (2011-2016)
Table United States Immune Checkpoint Inhibitor Market Share by Application (2011-2016)
Figure China Immune Checkpoint Inhibitor Sales and Growth Rate (2011-2016)
Figure China Immune Checkpoint Inhibitor Revenue and Growth Rate (2011-2016)
Figure China Immune Checkpoint Inhibitor Sales Price Trend (2011-2016)
Table China Immune Checkpoint Inhibitor Sales by Manufacturers (2011-2016)
Table China Immune Checkpoint Inhibitor Market Share by Manufacturers (2011-2016)
Table China Immune Checkpoint Inhibitor Sales by Type (2011-2016)
Table China Immune Checkpoint Inhibitor Market Share by Type (2011-2016)
Table China Immune Checkpoint Inhibitor Sales by Application (2011-2016)
Table China Immune Checkpoint Inhibitor Market Share by Application (2011-2016)
Figure Europe Immune Checkpoint Inhibitor Sales and Growth Rate (2011-2016)
Figure Europe Immune Checkpoint Inhibitor Revenue and Growth Rate (2011-2016)
Figure Europe Immune Checkpoint Inhibitor Sales Price Trend (2011-2016)
Table Europe Immune Checkpoint Inhibitor Sales by Manufacturers (2011-2016)
Table Europe Immune Checkpoint Inhibitor Market Share by Manufacturers (2011-2016)
Table Europe Immune Checkpoint Inhibitor Sales by Type (2011-2016)
Table Europe Immune Checkpoint Inhibitor Market Share by Type (2011-2016)
Table Europe Immune Checkpoint Inhibitor Sales by Application (2011-2016)
Table Europe Immune Checkpoint Inhibitor Market Share by Application (2011-2016)
Figure Japan Immune Checkpoint Inhibitor Sales and Growth Rate (2011-2016)
Figure Japan Immune Checkpoint Inhibitor Revenue and Growth Rate (2011-2016)
Figure Japan Immune Checkpoint Inhibitor Sales Price Trend (2011-2016)
Table Japan Immune Checkpoint Inhibitor Sales by Manufacturers (2011-2016)
Table Japan Immune Checkpoint Inhibitor Market Share by Manufacturers (2011-2016)
Table Japan Immune Checkpoint Inhibitor Sales by Type (2011-2016)
Table Japan Immune Checkpoint Inhibitor Market Share by Type (2011-2016)
Table Japan Immune Checkpoint Inhibitor Sales by Application (2011-2016)
Table Japan Immune Checkpoint Inhibitor Market Share by Application (2011-2016)
Table Bristol-Myers Squibb Basic Information List
Table Bristol-Myers Squibb Immune Checkpoint Inhibitor Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Bristol-Myers Squibb Immune Checkpoint Inhibitor Global Market Share (2011-2016)
Table Eli Lilly and Company Basic Information List
Table Eli Lilly and Company Immune Checkpoint Inhibitor Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Eli Lilly and Company Immune Checkpoint Inhibitor Global Market Share (2011-2016)
Table Merck & Co. Basic Information List
Table Merck & Co. Immune Checkpoint Inhibitor Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Merck & Co. Immune Checkpoint Inhibitor Global Market Share (2011-2016)
Table Roche Basic Information List
Table Roche Immune Checkpoint Inhibitor Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Roche Immune Checkpoint Inhibitor Global Market Share (2011-2016)
Table Taiho Pharmaceutical Basic Information List
Table Taiho Pharmaceutical Immune Checkpoint Inhibitor Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Taiho Pharmaceutical Immune Checkpoint Inhibitor Global Market Share (2011-2016)
Table Sumitomo Dainippon Pharma Basic Information List
Table Sumitomo Dainippon Pharma Immune Checkpoint Inhibitor Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Sumitomo Dainippon Pharma Immune Checkpoint Inhibitor Global Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Immune Checkpoint Inhibitor
Figure Manufacturing Process Analysis of Immune Checkpoint Inhibitor
Figure Immune Checkpoint Inhibitor Industrial Chain Analysis
Table Raw Materials Sources of Immune Checkpoint Inhibitor Major Manufacturers in 2015
Table Major Buyers of Immune Checkpoint Inhibitor
Table Distributors/Traders List
Figure Global Immune Checkpoint Inhibitor Sales and Growth Rate Forecast (2016-2021)
Figure Global Immune Checkpoint Inhibitor Revenue and Growth Rate Forecast (2016-2021)
Table Global Immune Checkpoint Inhibitor Sales Forecast by Regions (2016-2021)
Table Global Immune Checkpoint Inhibitor Sales Forecast by Type (2016-2021)
Table Global Immune Checkpoint Inhibitor Sales Forecast by Application (2016-2021)


More Publications